EU - HealthQuill

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

by HealthQuill
August 20, 2024
0 Comments

The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic adults with obesity, according to a statement from the EU regulator.

Drugs Health Pharma

Wegovy gets EU regulator backing on lowering heart risks in obese people

The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.

by HealthQuill
July 26, 2024
0 Comments

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

Drugs Health Pharma

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

by HealthQuill
July 17, 2024
0 Comments

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according to a company statement.

Drugs Health Pharma

FDA approves AstraZeneca’s type-2 diabetes drug in US market

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according.

by HealthQuill
June 13, 2024
0 Comments

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus vaccine from CSL Sequris UK Ltd., over a maximum period of four years to prevent the spread or potential outbreaks of bird flu in the region.

Drugs Health Pharma

EU to procure 40 million doses of avian flu vaccine from CSL Seqirus

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus.

by HealthQuill
June 12, 2024
0 Comments

Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.

Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance.

by HealthQuill
May 13, 2024
0 Comments

Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian influenza virus acquires the ability to spread quickly, according to the European Food Safety Authority (EFSA).

Drugs Health Pharma

EFSA issues warning on bird flu spread, says humans lack immunity

HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian.

by HealthQuill
April 3, 2024
0 Comments

Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.

Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

by HealthQuill
December 22, 2023
0 Comments

France has started a vaccination programme for farmed ducks to protect them against highly pathogenic avian influenza (HPAI) inviting a US ban on poultry imports from that country and the EU.

Drugs Health Pharma

France’s decision to vaccinate ducks against HPAI virus invites US ban

HQ Team October 3, 2023: France has started a vaccination programme for farmed ducks to protect them against highly pathogenic avian influenza (HPAI).